explore -WSS

explore

author：fashion 2025-08-26 07:45:14 - browse：12118

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round.

The company, BioAge, raised money from more than a dozen investors. Sofinnova Investments led the round, which also included Eli Lilly and Amgen’s venture arms and previous investor Andreessen Horowitz.

BioAge’s primary focus is in developing medications that boost a person’s healthspan, or the number of healthy years a person lives. The company has drugs in development for neuroinflammation and brain aging. But the majority of the Series D proceeds will be used to develop the company’s lead drug candidate azelaprag, which is being tested in combination with Zepbound. That drug program is what grabbed Sofinnova’s attention, according to managing partner Jim Healy, who recently became chairman of BioAge’s board.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： A strong 6.5

entertainment

WSS

Flagship, Pfizer team up in deal worth up to $7 billion

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Flagship, Pfizer team up in deal worth up to $7 billion

ER docs worry over extreme heat as a 'mass casualty event'

US soldier in North Korean custody after crossing DMZ line

Why you get paid to donate plasma but not blood

explore

explore

knowledge

Bright Health sells Medicare Advantage business to Molina

Goldman Sachs launches $650M fund for life science investments

Wildfire smoke exposes gaps in outdoor worker protections

UCB departs biotech trade group BIO

Walensky prepares to leave CDC — and Congress — behind

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

23andMe had bad news about my health. I wish a person had delivered it

BridgeBio heart drug succeeds in pivotal study

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Wikipedia

A single drug, study failures leave Anavex with nothing but cash

Johnson & Johnson sues to stop Medicare negotiation

New weight loss drugs work. But how can they best be used?

3 medical device trends to watch in 2024

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Videos point to link between seizures and unexplained toddler deaths

hotspot

leisure time

entertainment

hotspot